Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 6/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | RRM1 | P23921 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13956914 | 0.93 | USP2 (0.47) | USP2CA2CA1TSHRDPP7 | |
| SCHEMBL13956920 | 0.93 | USP2 (0.47) | USP2CA2CA1TSHRDPP7 | |
| SCHEMBL14028158 | 0.89 | USP2 (0.57) | USP2CA2CA1TSHRDPP7 | |
| SCHEMBL5491789 | 0.82 | USP2 (0.71) | USP2CA2CA1TSHRDPP7 | |
| SCHEMBL28996826 | 0.81 | MMP2 (0.36) | USP2TSHRDPP7MEN1KMT2A | |
| SCHEMBL22414705 | 0.81 | USP2 (0.69) | USP2CA2CA1TSHRDPP7 | |
| SCHEMBL11692574 | 0.81 | USP2 (0.69) | USP2CA2CA1TSHRDPP7 | |
| SCHEMBL18541163 | 0.79 | USP2 (0.66) | USP2CA2CA1TSHRDPP7 | |
| SCHEMBL12134681 | 0.78 | GAA (0.38) | USP2TSHRDPP7ALDH1A1MEN1 | |
| SCHEMBL16390491 | 0.78 | USP2 (0.65) | USP2CA2CA1TSHRDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795058-B2 | Silicon dioxide composite particle with far-infrared radioactivity; precursor of the same and application thereof | NATIONAL CHI NAN UNIVERSITY (TW) | 2023-10-24 | — | — | US | disclosed |
| US-11795058-B2 | Silicon dioxide composite particle with far-infrared radioactivity; precursor of the same and application thereof | NATIONAL CHI NAN UNIVERSITY (TW) | 2023-10-24 | — | — | US | disclosed |
| US-11795058-B2 | Silicon dioxide composite particle with far-infrared radioactivity; precursor of the same and application thereof | NATIONAL CHI NAN UNIVERSITY (TW) | 2023-10-24 | — | — | US | disclosed |
| CN-111285895-A | Silicon dioxide composite particle with far infrared radiation, organic precursor thereof and application of composite particle | 赖荣豊 | 2020-06-16 | — | — | CN | disclosed |
| US-20200180967-A1 | SILICON DIOXIDE COMPOSITE PARTICLE WITH FAR-INFRARED RADIOACTIVITY; PRECURSOR OF THE SAME AND APPLICATION THEREOF | Great Chain Chemical Ltd. (TW) | 2020-06-11 | — | — | US | disclosed |
| US-20200180967-A1 | SILICON DIOXIDE COMPOSITE PARTICLE WITH FAR-INFRARED RADIOACTIVITY; PRECURSOR OF THE SAME AND APPLICATION THEREOF | Great Chain Chemical Ltd. (TW) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795058-B2 | Silicon dioxide composite particle with far-infrared radioactivity; precursor of the same and application thereof | MSR1, SIK2, FAR1 | USP2 2092/4885CA2 889/4885CA1 110/4885 |
| US-20200180967-A1 | SILICON DIOXIDE COMPOSITE PARTICLE WITH FAR-INFRARED RADIOACTIVITY; PRECURSOR OF THE SAME AND APPLICATION THEREOF | MSR1, SIK2, FAR1 | USP2 2092/4885CA2 889/4885CA1 110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.